Documentos de Egea M.A. | REDI

Regresar

Mostrando 4 resultados de: 4

Subtipo de publicación

Publisher

Colloids and Surfaces B: Biointerfaces(1)

Journal of Nanobiotechnology(1)

Nanomedicine: Nanotechnology, Biology, and Medicine(1)

Área temáticas

Enfermedades(3)

Medicina y salud(3)

Farmacología y terapéutica(2)

Salud y seguridad personal(1)

Área de conocimiento

Farmacología(3)

Biotecnología(1)

Ciencia de materiales(1)

Nanopartícula(1)

Año de Publicación

Origen

Palabras Claves

Nanoparticles(3)

Alzheimer's disease(2)

Dexibuprofen(2)

New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9

Abstract: Dexibuprofen loaded pegylated poly(lactic-co-glycolic) nanospheres prepared by solvent diffusion met

Palabras claves:

Alzheimer's disease, Blood–Brain barrier, Dexibuprofen, Nanoparticles, Nanospheres, PLGA-PEG

Antoni Camins, Calpena A.C., Egea M.A., Espina M., Ettcheto M., Folch J., García M.L., Sanchez-Lopez E.

PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization

Abstract: Dexibuprofen-loaded PEGylated PLGA nanospheres have been developed to improve the biopharmaceutical

Palabras claves:

Dexibuprofen, drug delivery, inflammation, Nanospheres, PEG, PLGA

Antoni Camins, Calpena A.C., Cano A., Egea M.A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Silva A.M., Souto E.M.B.

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: In vitro and in vivo characterization

Abstract: Background: Memantine, drug approved for moderate to severe Alzheimer's disease, has not shown to be

Palabras claves:

Alzheimer's disease, APPswe/PS1dE9 mice, astrocytes, BEnd.3, Brain targeting, Memantine, Nanoparticles, β-Amyloid plaques

Antoni Camins, Calpena A.C., Cano A., Carmona N., Egea M.A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Silva A.M., Souto E.M.B.

Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma

Abstract: Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC)

Palabras claves:

drug delivery, glaucoma, Memantine, Nanoparticles, PLGA-PEG

Antoni Camins, Calpena A.C., Cordeiro M.F., Davis B.M., Egea M.A., Espina M., Ettcheto M., García M.L., Guo L., Ravindran N., Sanchez-Lopez E., Silva A.M., Souto E.M.B.